Back to search
FDAFDA · Food and drugs·Recall number Z-0452-2015

Discovery IGS 740 Indicated for use for patients from newborn to geriatric in generating fluoroscopic and rotational images of human anatomy for cardiovascular, vascular and non-vascular, diagnostic and interventional procedures.

Published December 24, 2014 · Recall initiated: September 4, 2014

Summary

FDA records medical device Class II recall Z-0452-2015, published December 24, 2014 and initiated September 4, 2014. Recalling firm: GE Healthcare, LLC; Status: Terminated; Reported quantity: 1 - OUS; Lot: Mfg Lot or Serial # System ID 00000646778BU1 190020RX26. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Loss of imaging - affected devices may experience a loss of real-time interventional imaging and/or gantry motion due to the Electromagnetic (EM) sensitivity of the grid detection mechanism.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
GE Healthcare, LLC
Distributor
Worldwide Distribution -- US, including the states of CA, CO, FL, MO, PA; and, the countries of BELGIUM, CHINA, COLOMBIA, FRANCE, GREECE, MEXICO, and RUSSIA.
Lot
Mfg Lot or Serial # System ID 00000646778BU1 190020RX26
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Discovery IGS 740 Indicated for use for patients from newborn to geriatric in generating fluoroscopic and rotational images of human anatomy for cardiovascular, vascular and non-vascular, diagnostic and interventional procedures. recalled?

Yes. FDA published recall Z-0452-2015 on December 24, 2014. Reported hazard: Loss of imaging - affected devices may experience a loss of real-time interventional imaging and/or gantry motion due to the Electromagnetic (EM) sensitivity of the grid detection mechanism.

What should I do if I have this product?

Voluntary: Firm initiated · Letter